Overview

Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate pharmacokinetics, metabolomics and biomarker in subjects who are overweight and have liver problems after ursodeoxycholic acid multiple administration
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Metformin
Ursodeoxycholic Acid